Related Experiment Video
Updated: Sep 22, 2025

Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry
Published on: October 18, 2016
MicroRNA-382 Promotes M2-Like Macrophage via the SIRP-α/STAT3 Signaling Pathway in Aristolochic Acid-Induced Renal
Xiaoyan Wang1,2,3, Ping Jia1,2,3,4, Ting Ren1,2,3
1Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Abstract:
Aristolochic acid nephropathy (AAN) is a type of drug-induced nephropathy and is correlated with a potentially progression of kidney fibrosis. However, whether miR-382 is implicated in macrophage activation in AA-induced kidney fibrosis remains elusive. Here, cell-sorting experiments defined a significant miR-382 enrichment in renal macrophage after AAN 14 days. Then, we found that treatment of AA induced a significant switch in the phenotype of macrophage both in vivo and in vitro. Furthermore, miR-382 knockout (KO) mice and miR-382-/- bone marrow-derived macrophage (BMDM) were subjected to AA induction. We found that both systemic KO and macrophage-specific miR-382 depletion notably suppressed M2-like macrophage activation as well as kidney interstitial fibrosis. Additionally, adoptive transfer of miR-382 overexpression BMDMs into mice promoted AA-induced kidney injury. Moreover, in cultured macrophage, upregulation of miR-382 promoted M2-related gene expression, accompanied by downregulation of signal regulatory protein α (SIRP-α) and activation of signal transducer and activator of transcription 3 (STAT3). The interaction between miR-382 and SIRP-α was evaluated via dual-luciferase assay. Knockdown of SIRP-α upregulated phosphorylated STAT3 at S727 and Y705. Pharmacological inhibition of STAT3 was performed both in vivo and in vitro. Inhibition of STAT3 attenuated AA-induced kidney fibrosis, in parallel to lesser macrophage M2 polarization. Coculture experiments further confirmed that overexpressed miR-382 in macrophage promoted injuries of tubular cells. Luminex bio-chip detection suggested that IL-4 and CCL-5 were critical in the cross talk between macrophages and tubular cells. Taken together, our data suggest that miR-382 is a critical mediator in M2-like macrophage polarization and can be a promising therapeutic target for kidney fibrosis.
Insights
MicroRNA-382 drives kidney fibrosis by promoting M2 macrophage activation in aristolochic acid nephropathy. Inhibiting miR-382 or STAT3 may offer therapeutic strategies for this kidney disease.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Aristolochic acid nephropathy (AAN) is linked to kidney fibrosis.
- The role of microRNA-382 (miR-382) in macrophage activation during AAN is unknown.
Purpose of the Study:
- Investigate miR-382's role in macrophage activation and kidney fibrosis in AAN.
- Determine if miR-382 is a potential therapeutic target for AAN.
Main Methods:
- Cell sorting to identify miR-382 in renal macrophages.
- miR-382 knockout mice and bone marrow-derived macrophages (BMDM) subjected to aristolochic acid (AA).
- Adoptive transfer, dual-luciferase assay, STAT3 inhibition, and coculture experiments.
Main Results:
- miR-382 is enriched in renal macrophages in AAN and promotes M2 polarization.
- miR-382 knockout or depletion suppresses M2 activation and kidney fibrosis.
- miR-382 targets SIRP-α, activating STAT3 and promoting macrophage-tubular cell crosstalk.
- STAT3 inhibition reduces fibrosis and M2 polarization.
Conclusions:
- miR-382 is a key mediator of M2-like macrophage polarization in AAN.
- miR-382 and STAT3 signaling are critical in AA-induced kidney fibrosis.
- miR-382 represents a promising therapeutic target for kidney fibrosis.

